The cyclin-dependent kinase inhibitor p21 (CDKN1A) behaves in fundamentally opposing ways across exercise contexts in the aging brain. Sustained physiological exercise attenuates p21-associated stress signatures in hippocampal and cortical tissue across models of natural aging, metabolic distress, and amyloid pathology. Yet acute treadmill bouts transiently elevate hippocampal Cdkn1a, spatial transcriptomics reveals endothelial Cdkn1a increases during vascular rejuvenation, and excessive swimming drives sustained p53-p21 activation alongside oxidative injury, senescence-associated β-galactosidase activity, apoptosis, and cognitive decline — a complete maladaptive cascade.
This framework matters because the field has loosely equated exercise with anti-senescence benefit without mechanistic precision. The three-state model proposed here — stress-preventive attenuation, transient adaptive induction, and maladaptive overload — reframes p21 not as a uniform biomarker of exercise benefit or harm, but as a context-sensitive signal requiring temporal and cell-type resolution. Critically, the review distinguishes senomorphic effects (dampening senescence-associated secretory phenotype without clearing senescent cells) from senolytic effects, and current evidence supports only the former for exercise in the CNS. For adults pursuing longevity-oriented exercise, this underscores that overtraining carries a neurobiological cost measurable at the molecular level. Key limitations: virtually all direct mechanistic evidence is preclinical, and human CNS p21 dynamics during exercise remain essentially unmapped. This is confirmatory and synthesizing rather than paradigm-shifting, but the interpretive matrix offers a useful scaffold for designing future dose-response human trials.